News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,279 Results
Type
Article (48955)
Company Profile (310)
Press Release (684013)
Multimedia
Podcasts (80)
Webinars (15)
Section
Business (210456)
Career Advice (2411)
Deals (36197)
Drug Delivery (114)
Drug Development (82859)
Employer Resources (192)
FDA (16527)
Job Trends (15365)
News (354978)
Policy (33612)
Tag
Academia (2793)
Academic (2)
Accelerated approval (9)
Adcomms (25)
Allergies (97)
Alliances (51644)
ALS (113)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (159)
Approvals (16515)
Artificial intelligence (338)
Autoimmune disease (29)
Automation (18)
Bankruptcy (368)
Best Places to Work (11889)
BIOSECURE Act (20)
Biosimilars (123)
Biotechnology (209)
Bladder cancer (95)
Brain cancer (33)
Breast cancer (367)
Cancer (2911)
Cardiovascular disease (218)
Career advice (2019)
Career pathing (33)
CAR-T (196)
CDC (36)
Cell therapy (524)
Cervical cancer (23)
Clinical research (67853)
Collaboration (1053)
Company closure (3)
Compensation (690)
Complete response letters (26)
COVID-19 (2724)
CRISPR (62)
C-suite (334)
Cystic fibrosis (113)
Data (3018)
Decentralized trials (2)
Denatured (34)
Depression (64)
Diabetes (349)
Diagnostics (6658)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (48)
Drug discovery (145)
Drug pricing (132)
Drug shortages (29)
Duchenne muscular dystrophy (127)
Earnings (88527)
Editorial (43)
Employer branding (25)
Employer resources (164)
Events (117976)
Executive appointments (872)
FDA (18190)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (968)
Gene editing (139)
Generative AI (25)
Gene therapy (396)
GLP-1 (833)
Government (4695)
Grass and pollen (4)
Guidances (181)
Healthcare (19342)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (155)
Immuno-oncology (8)
Indications (39)
Infectious disease (2900)
Inflammatory bowel disease (155)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (121)
Interviews (396)
IPO (16866)
IRA (46)
Job creations (3876)
Job search strategy (1708)
Kidney cancer (13)
Labor market (55)
Layoffs (521)
Leadership (22)
Legal (8161)
Liver cancer (81)
Lung cancer (411)
Lymphoma (209)
Machine learning (11)
Management (62)
Manufacturing (400)
MASH (92)
Medical device (13678)
Medtech (13683)
Mergers & acquisitions (20049)
Metabolic disorders (874)
Multiple sclerosis (99)
NASH (22)
Neurodegenerative disease (121)
Neuropsychiatric disorders (34)
Neuroscience (2192)
NextGen: Class of 2025 (6798)
Non-profit (4690)
Now hiring (48)
Obesity (448)
Opinion (243)
Ovarian cancer (103)
Pain (111)
Pancreatic cancer (123)
Parkinson's disease (190)
Partnered (22)
Patents (302)
Patient recruitment (165)
Peanut (52)
People (59937)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (21185)
Phase II (29856)
Phase III (22218)
Pipeline (1640)
Policy (209)
Postmarket research (2658)
Preclinical (9280)
Press Release (72)
Prostate cancer (140)
Psychedelics (39)
Radiopharmaceuticals (259)
Rare diseases (473)
Real estate (6270)
Recruiting (74)
Regulatory (23267)
Reports (59)
Research institute (2521)
Resumes & cover letters (420)
Rett syndrome (9)
RNA editing (9)
RSV (51)
Schizophrenia (90)
Series A (166)
Series B (113)
Service/supplier (14)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (152)
Sponsored (34)
Startups (3816)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (59)
The Weekly (44)
Vaccines (817)
Venture capital (55)
Weight loss (274)
Women's health (49)
Worklife (19)
Date
Today (70)
Last 7 days (385)
Last 30 days (1914)
Last 365 days (31873)
2025 (17101)
2024 (36109)
2023 (41043)
2022 (52117)
2021 (56741)
2020 (55201)
2019 (47969)
2018 (36208)
2017 (33378)
2016 (33020)
2015 (39071)
2014 (32708)
2013 (27876)
2012 (30121)
2011 (30861)
2010 (29357)
Location
Africa (822)
Alabama (63)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (40335)
Australia (6676)
California (7544)
Canada (2370)
China (680)
Colorado (330)
Connecticut (321)
Delaware (193)
Europe (88472)
Florida (1121)
Georgia (257)
Hawaii (2)
Idaho (60)
Illinois (654)
India (28)
Indiana (370)
Iowa (17)
Japan (230)
Kansas (110)
Kentucky (31)
Louisiana (15)
Maine (64)
Maryland (1038)
Massachusetts (5638)
Michigan (264)
Minnesota (469)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (68)
New Jersey (2104)
New Mexico (30)
New York (2119)
North Carolina (1129)
North Dakota (10)
Northern California (3309)
Ohio (238)
Oklahoma (16)
Oregon (35)
Pennsylvania (1621)
Puerto Rico (17)
Rhode Island (36)
South America (1200)
South Carolina (34)
South Dakota (1)
Southern California (2818)
Tennessee (127)
Texas (1138)
United States (28064)
Utah (225)
Virginia (186)
Washington D.C. (77)
Washington State (649)
West Virginia (4)
Wisconsin (80)
733,279 Results for "applied dna sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
July 1, 2025
·
6 min read
Press Releases
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
June 18, 2025
·
5 min read
Press Releases
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
June 2, 2025
·
2 min read
Press Releases
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results
May 15, 2025
·
15 min read
Press Releases
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
June 17, 2025
·
1 min read
Press Releases
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
May 29, 2025
·
5 min read
Press Releases
Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
April 22, 2025
·
4 min read
Pharm Country
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
May 28, 2024
·
5 min read
Business
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced consolidated financial results for its second fiscal quarter ended March 31, 2024.
May 10, 2024
·
11 min read
Deals
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
May 10, 2024
·
3 min read
1 of 73,328
Next
